Observation of Composite Salvia Injection Combined with Ulinastatin in Treatment of Acute Pancreatitis
Xian Zhao
Abstract
Xian Zhao
Abstract
Objective: To explore the effect of composite salvia injection combined with ulnastatin in treatments of acute pancreatitis. Method: One hundred and sixteen cases with acute pancreatitis were randomly divided into control group and experience group. Control group was given routine treatment and ulinastatin quiescent point. Experience group received composite salvia injection combined with ulinastatin therapy. Clinical efficacy,laboratory indexes and inflammatory factors were compared between two groups. Result: The effective rates of treatment in experience group were much higher than that in control group( 93. 3% vs 80. 4%,P 0. 05). Hospital stay in experience group was much less than that in control group( P 0. 05); comparison with control group,blood amylase,leukocyte,interleukin-6( IL-6) and tumor necrosis factor-α( TNF-α) after treatment in experience group greatly decreased( P 0. 05). Conclusion: Composite salvia injection combined with ulinastatin for acute pancreatitis greatly decrease the serum inflammatory factors and improve the clinical efficacy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To explore the effect of composite salvia injection combined with ulnastatin in treatments of acute pancreatitis. Method: One hundred and sixteen cases with acute pancreatitis were randomly divided into control group and experience group. Control group was given routine treatment and ulinastatin quiescent point. Experience group received composite salvia injection combined with ulinastatin therapy. Clinical efficacy,laboratory indexes and inflammatory factors were compared between two groups. Result: The effective rates of treatment in experience group were much higher than that in control group( 93. 3% vs 80. 4%,P 0. 05). Hospital stay in experience group was much less than that in control group( P 0. 05); comparison with control group,blood amylase,leukocyte,interleukin-6( IL-6) and tumor necrosis factor-α( TNF-α) after treatment in experience group greatly decreased( P 0. 05). Conclusion: Composite salvia injection combined with ulinastatin for acute pancreatitis greatly decrease the serum inflammatory factors and improve the clinical efficacy.
Key concepts: Ulinastatin, Medicine, Acute pancreatitis, Salvia, Pancreatitis, Gastroenterology, Surgery, Internal medicine